Mapping the central effects of ketamine in the rat using pharmacological MRI.
about
In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects.Relating Translational Neuroimaging and Amperometric Endpoints: Utility for Neuropsychiatric Drug Discovery.Dissociable effects of antipsychotics on ketamine-induced changes in regional oxygenation and inter-regional coherence of low frequency oxygen fluctuations in the rat.Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain.Ethanol-induced alterations of amino acids measured by in vivo microdialysis in rats: a meta-analysis.A rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes.Selective potentiation of the metabotropic glutamate receptor subtype 2 blocks phencyclidine-induced hyperlocomotion and brain activation.¹H-[¹³C]-nuclear magnetic resonance spectroscopy measures of ketamine's effect on amino acid neurotransmitter metabolismNeural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.The in vivo neurochemistry of the brain during general anesthesia.Sub-anesthetic ketamine modulates intrinsic BOLD connectivity within the hippocampal-prefrontal circuit in the rat.Differential Effects of Anaesthesia on the phMRI Response to Acute Ketamine Challenge.Subchronic memantine induced concurrent functional disconnectivity and altered ultra-structural tissue integrity in the rodent brain: revealed by multimodal MRI.The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders.Subanesthetic ketamine decreases the incentive-motivational value of reward-related cues.Examination of clozapine and haloperidol in improving ketamine-induced deficits in an incremental repeated acquisition procedure in BALB/c mice.Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe.Ketamine disrupts theta synchrony across the septotemporal axis of the CA1 region of hippocampus.Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics.N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI.Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia.Convergence of human brain mapping tools: Neuronavigated TMS Parameters and fMRI activity in the hand motor areaNeuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging
P2860
Q30413276-E34EA3E3-6C35-4E51-92E5-2CD67ABF296CQ30483032-35EED9EE-6EFD-4328-94CF-D4CCDB74984AQ30841490-1A625F9B-1CBE-4946-A831-FC9D5DCB7961Q31064532-59E3F01E-56E1-458A-B000-7346938F7107Q33620557-0C423C97-1F48-4C62-A900-FC30B2D12ECAQ34229087-4BEEC90F-79AB-412E-8B5A-A57DF80662B2Q34503542-FF319910-F20A-40EC-85BB-0DF3EA9ADF0AQ35157981-85DDD6C2-9C56-4E8B-9096-05575350D2AEQ36687682-E6C1D8EA-C635-4278-A140-2BB987234A4EQ36865559-D74F2F52-A18B-4A06-ACB9-1604A781AFC2Q36901682-F5C8DFFF-3D49-467A-B716-F4592715A785Q37924850-E0F335AB-8E75-484D-BC2F-25BD13BE179FQ41955383-68B13387-F985-4F9A-BB6C-4B4FB2750C0DQ42105125-DC5C8F5D-9EDE-4DFE-AA6B-934B64FDE99AQ45048328-5B5E9C5C-2021-4031-8743-7EE8F45E6C01Q46296210-C8B7E2E3-F736-4105-B424-6B1F89E82C0CQ47151084-04831683-446D-4E95-95C5-2B99FCD92B72Q47633556-005BD36E-274B-4BEA-8AA6-569E254808D5Q47679383-637ADFF7-6B47-4525-B967-E4EF00D0AA8EQ48119187-5890CF62-75A6-4F33-BB9C-F208D8FAA6A5Q48277673-26805DC9-C989-4BD4-B025-DA8935217FC1Q49466202-F037D897-A757-4307-A1B4-388756D3FF9AQ50442482-ECEA5325-336D-4D3C-892D-AAE8413EB451Q57514561-D3DD8244-F35D-4F71-94AB-520AA068A84DQ58197638-C4443C59-0874-459A-A600-136083085849
P2860
Mapping the central effects of ketamine in the rat using pharmacological MRI.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Mapping the central effects of ketamine in the rat using pharmacological MRI.
@en
Mapping the central effects of ketamine in the rat using pharmacological MRI.
@nl
type
label
Mapping the central effects of ketamine in the rat using pharmacological MRI.
@en
Mapping the central effects of ketamine in the rat using pharmacological MRI.
@nl
prefLabel
Mapping the central effects of ketamine in the rat using pharmacological MRI.
@en
Mapping the central effects of ketamine in the rat using pharmacological MRI.
@nl
P2093
P2860
P1433
P1476
Mapping the central effects of ketamine in the rat using pharmacological MRI.
@en
P2093
Clare L Littlewood
Mark Tricklebank
Michael J O'Neill
Nicholas Jones
Stephen N Mitchell
P2860
P2888
P356
10.1007/S00213-006-0344-0
P577
2006-03-21T00:00:00Z